Platelets inhibit development of atherosclerosis in atherosclerotic mice

References

• Shapiro MD, Fazio S. From lipids to inflammation: new approaches to reducing atherosclerotic risk[J]. Circ Res. 2016;118(4):732–749.
   PubMed Web of Science ®Google Scholar
• Mclaren JE, Michael DR, Ashlin TG, et al. Cytokines, macrophage lipid metabolism and foam cells: implications for cardiovascular disease therapy[J]. Prog Lipid Res. 2011;50(4):331–347.
   PubMed Web of Science ®Google Scholar
• Williams JW, Giannarelli C, Rahman A, et al. Macrophage biology, classification, and phenotype in cardiovascular disease: JACC macrophage in CVD series (Part 1)[J]. J Am Coll Cardiol. 2018;72(18):2166–2180.
   PubMed Web of Science ®Google Scholar
• Bories G, Leitinger N. Macrophage metabolism in atherosclerosis[J]. FEBS Lett. 2017;591(19):3042–3060.
   PubMed Web of Science ®Google Scholar
• Ma J, Liu C, Yang Y, et al. C/EBPbeta acts upstream of NF-kappaB P65 subunit in Ox-LDL-induced IL-1beta production by macrophages[J]. Cell Physiol Biochem. 2018;48(4):1605–1615.
   PubMedGoogle Scholar
• Yeung J, Li W, Holinstat M. Platelet signaling and disease: targeted therapy for thrombosis and other related diseases[J]. Pharmacol Rev. 2018;70(3):526–548.
   PubMed Web of Science ®Google Scholar
• van der Meijden P, Heemskerk J. Platelet biology and functions: new concepts and clinical perspectives[J]. Nat Rev Cardiol. 2019;16(3):166–179.
   PubMed Web of Science ®Google Scholar
• Xiang B, Zhang G, Guo L, et al. Platelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway[J]. Nat Commun. 2013;4(1):2657.
   PubMedGoogle Scholar
• Zhang G, Xiang B, Ye S, et al. Distinct roles for Rap1b protein in platelet secretion and integrin αIIbβ3 outside-in signaling[J]. J Biol Chem. 2011;286(45):39466–39477.
   PubMed Web of Science ®Google Scholar
• Kanda T, Hayashi K, Wakino S, et al. Role of Rho-kinase and p27 in angiotensin II-induced vascular injury[J]. Hypertension. 2005;45(4):724–729.
   PubMed Web of Science ®Google Scholar
• Lewis P, Stefanovic N, Pete J, et al. Lack of the antioxidant enzyme glutathione peroxidase-1 accelerates atherosclerosis in diabetic apolipoprotein E-deficient mice[J]. Circulation. 2007;115(16):2178–2187.
   PubMed Web of Science ®Google Scholar
• Remmerie A, Scott CL. Macrophages and lipid metabolism[J]. Cell Immunol. 2018;330:27–42.
   PubMed Web of Science ®Google Scholar
• Ai XM, Ho LC, Han LL, et al. The role of splenectomy in lipid metabolism and atherosclerosis (AS)[J]. Lipids Health Dis. 2018;17(1):186.
   PubMedGoogle Scholar
• Emini VB, Perrotta P, De Meyer G, et al. Animal models of atherosclerosis[J]. Eur J Pharmacol. 2017;816:3–13.
   PubMed Web of Science ®Google Scholar
• Ding L, Chang M, Guo Y, et al. Trimethylamine-N-oxide (TMAO)-induced atherosclerosis is associated with bile acid metabolism[J]. Lipids Health Dis. 2018;17(1):286.
   PubMedGoogle Scholar
• Li J, Lin S, Vanhoutte PM, et al. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe−/− mice[J]. Circulation. 2016;133(24):2434–2446.
   PubMed Web of Science ®Google Scholar
• Zhu B, Zhai Y, Ji M, et al. Alisma orientalis beverage treats atherosclerosis by regulating gut microbiota in ApoE−/− mice. Front Pharmacol. 2020;11:570555.
   PubMed Web of Science ®Google Scholar
• Geng J, Yang C, Wang B, et al. Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK/JNK pathway[J]. Biomed Pharmacother. 2018;97:941–947.
   PubMed Web of Science ®Google Scholar
• Gotto AJ, Brinton EA. Assessing low levels of high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report and update[J]. J Am Coll Cardiol. 2004;43(5):717–724.
   PubMed Web of Science ®Google Scholar
• Rosenson RS, Davidson MH, Hirsh BJ, et al. Genetics and causality of triglyceride-rich lipoproteins in atherosclerotic cardiovascular disease[J]. J Am Coll Cardiol. 2014;64(23):2525–2540.
   PubMed Web of Science ®Google Scholar
• Dron JS, Hegele RA. Genetics of triglycerides and the risk of atherosclerosis[J]. Curr Atheroscler Rep. 2017;19(7):31.
   PubMed Web of Science ®Google Scholar
• Chen T, Huang W, Qian J, et al. Macrophage-derived myeloid differentiation protein 2 plays an essential role in ox-LDL-induced inflammation and atherosclerosis[J]. EBioMedicine. 2020;53:102706.
   PubMed Web of Science ®Google Scholar
• Du Y, Li X, Su C, et al. Butyrate protects against high-fat diet-induced atherosclerosis via up-regulating ABCA1 expression in apolipoprotein E-deficiency mice[J]. Br J Pharmacol. 2020;177(8):1754–1772.
   PubMed Web of Science ®Google Scholar
• Kosmas CE, Martinez I, Sourlas A, et al. High-density lipoprotein (HDL) functionality and its relevance to atherosclerotic cardiovascular disease[J]. Drugs Context. 2018;7:212525.
   PubMedGoogle Scholar
• Kizilay MO, Lora M, Shum-Tim D, et al. A proinflammatory secretome mediates the impaired immunopotency of human mesenchymal stromal cells in elderly patients with atherosclerosis[J]. Stem Cells Transl Med. 2017;6(4):1132–1140.
   PubMed Web of Science ®Google Scholar
• Basurto L, Gregory MA, Hernandez SB, et al. Monocyte chemoattractant protein-1 (MCP-1) and fibroblast growth factor-21 (FGF-21) as biomarkers of subclinical atherosclerosis in women[J]. Exp Gerontol. 2019;124:110624.
   PubMed Web of Science ®Google Scholar
• Hamlat-Khennaf N, Neggazi S, Ayari H, et al. [Inflammation in the perivascular adipose tissue and atherosclerosis][J]. C R Biol. 2017;340(3):156–163.
   PubMedGoogle Scholar
• Zhang Y, Yang X, Bian F, et al. TNF-alpha promotes early atherosclerosis by increasing transcytosis of LDL across endothelial cells: crosstalk between NF-kappaB and PPAR-gamma[J]. J Mol Cell Cardiol. 2014;72:85–94.
   PubMed Web of Science ®Google Scholar
• Tay C, Liu YH, Hosseini H, et al. B-cell-specific depletion of tumour necrosis factor alpha inhibits atherosclerosis development and plaque vulnerability to rupture by reducing cell death and inflammation[J]. Cardiovasc Res. 2016;111(4):385–397.
   PubMed Web of Science ®Google Scholar
• Gomez D, Baylis RA, Durgin BG, et al. Interleukin-1β has atheroprotective effects in advanced atherosclerotic lesions of mice[J]. Nat Med. 2018;24(9):1418–1429.
   PubMed Web of Science ®Google Scholar
• Khan R, Rheaume E, Tardif JC. Examining the role of and treatment directed at IL-1β in atherosclerosis. Curr Atheroscler Rep. 2018;20(11):53.
   PubMed Web of Science ®Google Scholar
• Yeh CC, Wu JY, Lee GL, et al. Vanadium derivative exposure promotes functional alterations of VSMCs and consequent atherosclerosis via ROS/p38/NF-kappaB-mediated IL-6 production[J]. Int J Mol Sci. 2019;20(24):6115.
   Web of Science ®Google Scholar
• Qiao J, Wu X, Luo Q, et al. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis[J]. Haematologica. 2018;103(9):1568–1576.
   PubMed Web of Science ®Google Scholar
• Morrell CN, Aggrey AA, Chapman LM, et al. Emerging roles for platelets as immune and inflammatory cells[J]. Blood. 2014;123(18):2759–2767.
   PubMed Web of Science ®Google Scholar
• Rossaint J, Margraf A, Zarbock A. Role of platelets in leukocyte recruitment and resolution of inflammation[J]. Front Immunol. 2018;9:2712.
   PubMed Web of Science ®Google Scholar
• Banerjee M, Whiteheart SW. The ins and outs of endocytic trafficking in platelet functions[J]. Curr Opin Hematol. 2017;24(5):467–474.
   PubMed Web of Science ®Google Scholar
• Carestia A, Mena HA, Olexen CM, et al. Platelets promote macrophage polarization toward pro-inflammatory phenotype and increase survival of septic mice[J]. Cell Rep. 2019;28(4):896–908.
   PubMed Web of Science ®Google Scholar